查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1876053

吸入式一氧化氮：全球市場佔有率和排名、總收入和需求預測（2025-2031年）

Inhaled Nitric Oxide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 87 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球吸入式一氧化氮市場預計在 2024 年達到 6.49 億美元，預計到 2031 年將達到 9.4 億美元，在預測期（2025-2031 年）內以 6.1% 的複合年成長率成長。

本報告對近期關稅調整和國際對吸入一氧化氮採取的戰略反制措施的跨境產業佈局、資本配置模式、區域經濟相互依存關係以及供應鏈重組進行了全面評估。

吸入一氧化氮（iNO）是一種廣泛用於治療呼吸系統疾病的氣體療法，特別適用於新生兒呼吸窘迫症候群（NRDS）和成人急性呼吸窘迫症候群（ARDS）。一氧化氮作為一種血管擴張劑，能夠擴張肺部的小血管，改善肺泡的通氣/血流比。這可以促進氧合併降低肺動脈壓。吸入一氧化氮的治療機制主要依賴其對肺血管平滑肌的直接作用，促進一氧化氮的釋放並增強血管舒張能力，從而有效改善患者的氧合和呼吸功能。

目前，吸入型一氧化氮產品主要包括氣體製劑及相關給藥裝置，例如吸入器和氣體濃度控制系統。這些產品已在許多國家和地區核准，並廣泛應用於新生兒加護病房（NICU）、成人加護病房（ICU）和急診室。隨著臨床需求的不斷成長，吸入型一氧化氮在各種呼吸系統疾病中的應用展現出巨大的潛力，尤其是在促進急性肺損傷患者的康復方面。

吸入式一氧化氮市場在全球範圍內持續成長，其原因主要有以下幾點：首先，呼吸系統疾病發病率的上升，尤其是在新生兒和老年人群中，推動了對吸入式一氧化氮的需求。吸入式一氧化氮能夠顯著改善急性呼吸窘迫症候群（ARDS）和其他肺部疾病患者的臨床症狀，縮短住院時間，並提高患者的生活品質，從而創造了強勁的市場需求。

其次，技術創新正在推動市場成長。新型給藥裝置不斷湧現，提高了吸入一氧化氮療法的療效和安全性。例如，便利的氣體濃度調節系統使患者能夠精確控制吸入劑量，從而減少副作用。此外，臨床研究表明，吸入一氧化氮療法不僅對新生兒有效，對重症患者也有效，展現了其廣闊的治療前景。

然而，該市場仍面臨許多挑戰和風險。首先，吸入一氧化氮療法的高成本是其廣泛應用的主要障礙，尤其是在開發中國家，高昂的治療費用限制了其普及。其次，儘管該療法已被廣泛用於治療某些疾病，但仍需更多臨床數據來驗證其療效和安全性，尤其是在非典型病例中。

市場集中度相對較高，主要由少數幾家在產品研發、行銷和臨床試驗方面經驗豐富的大型製藥和醫療設備公司主導。未來，隨著技術進步和治療方法的普及，市場集中度可能會降低。下游需求趨勢反映出對更個人化、更有效率治療方法的需求不斷成長，從而推動了客製化設備和新藥的研發。

本報告旨在按地區/國家、類型和應用程式對全球吸入式一氧化氮市場進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名。

吸入式一氧化氮市場規模、估算和預測以銷售量（百萬公升）和收入（百萬美元）為單位呈現，基準年為2024年，並包含2020年至2031年的歷史數據和預測數據。報告採用定量和定性分析相結合的方法，幫助讀者制定吸入式一氧化氮業務/成長策略，評估市場競爭，分析自身在當前市場中的地位，並做出明智的商業決策。

市場區隔

公司

  • Mallinckrodt（INOmax）
  • Linde（Noxivent）
  • Air Liquide（KINOX）

按類型分類的細分市場

  • 高純度一氧化氮
  • 標準純度iNO

應用領域

  • 新生兒持續性肺動脈高壓（PPHN）
  • ARDS
  • 其他疾病

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Inhaled Nitric Oxide was estimated to be worth US$ 649 million in 2024 and is forecast to a readjusted size of US$ 940 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Inhaled Nitric Oxide cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Inhaled Nitric Oxide (iNO) is a gas therapy widely used in the treatment of respiratory diseases, particularly neonatal respiratory distress syndrome (NRDS) and acute respiratory distress syndrome (ARDS) in adults. As a vasodilator, nitric oxide works by dilating the small blood vessels in the lungs, improving the matching of ventilation and blood flow in the alveoli, which in turn enhances oxygenation and reduces pulmonary arterial pressure. The therapeutic mechanism of inhaled nitric oxide primarily relies on its direct action on the smooth muscle of the pulmonary vessels, promoting the release of nitric oxide and thereby improving the vessel's ability to dilate, effectively improving the patient's oxygenation and respiratory function.

Currently, the products of inhaled nitric oxide mainly consist of gas formulations and related delivery devices, such as inhalers and gas concentration regulation systems. These products have been approved in many countries and regions and are widely used in neonatal intensive care units (NICU), adult ICUs, and emergency departments. With the increasing clinical demand, the application of inhaled nitric oxide in various respiratory diseases has a promising future, especially in promoting recovery in patients with acute lung injury.

The inhaled nitric oxide market continues to grow globally, driven by several factors. Firstly, with the rising incidence of respiratory diseases, particularly in neonatal and elderly populations, the demand for inhaled nitric oxide is increasing. Inhaled nitric oxide can significantly improve clinical symptoms in patients with acute respiratory distress syndrome and other pulmonary diseases, shorten hospital stays, and improve quality of life, thereby generating strong market demand.

Secondly, technological advancements are driving market growth. New delivery devices continue to emerge, enhancing the therapeutic efficacy and safety of inhaled nitric oxide. For example, convenient gas concentration regulation systems allow patients to precisely control their inhaled dosage, thus reducing side effects. Additionally, clinical research has shown that inhaled nitric oxide is effective not only in neonates but also in adult critically ill patients, demonstrating promising therapeutic potential.

However, the market also faces some challenges and risks. Firstly, the high cost of inhaled nitric oxide remains a significant barrier to widespread adoption, particularly in developing countries, where the expensive treatment cost limits its accessibility. Secondly, while inhaled nitric oxide has been widely used in treating specific diseases, its efficacy and safety still require further clinical data, especially in atypical cases.

The market concentration is relatively high, dominated by a few leading pharmaceutical and medical device companies, which have extensive experience in product development, marketing, and clinical trials. In the future, as technology advances and treatment methods become more widespread, market concentration may decrease. The downstream demand trend reflects a growing need for more personalized and efficient treatment methods, driving the development of customized devices and new drugs.

This report aims to provide a comprehensive presentation of the global market for Inhaled Nitric Oxide, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Inhaled Nitric Oxide by region & country, by Type, and by Application.

The Inhaled Nitric Oxide market size, estimations, and forecasts are provided in terms of sales volume (M L) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled Nitric Oxide.

Market Segmentation

By Company

  • Mallinckrodt (INOmax)
  • Linde (Noxivent)
  • Air Liquide (KINOX)

Segment by Type

  • High Purity iNO
  • Standard Purity iNO

Segment by Application

  • Infants PPHN
  • ARDS
  • Other Diseases

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Inhaled Nitric Oxide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Inhaled Nitric Oxide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Inhaled Nitric Oxide in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Inhaled Nitric Oxide Product Introduction
  • 1.2 Global Inhaled Nitric Oxide Market Size Forecast
    • 1.2.1 Global Inhaled Nitric Oxide Sales Value (2020-2031)
    • 1.2.2 Global Inhaled Nitric Oxide Sales Volume (2020-2031)
    • 1.2.3 Global Inhaled Nitric Oxide Sales Price (2020-2031)
  • 1.3 Inhaled Nitric Oxide Market Trends & Drivers
    • 1.3.1 Inhaled Nitric Oxide Industry Trends
    • 1.3.2 Inhaled Nitric Oxide Market Drivers & Opportunity
    • 1.3.3 Inhaled Nitric Oxide Market Challenges
    • 1.3.4 Inhaled Nitric Oxide Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Inhaled Nitric Oxide Players Revenue Ranking (2024)
  • 2.2 Global Inhaled Nitric Oxide Revenue by Company (2020-2025)
  • 2.3 Global Inhaled Nitric Oxide Players Sales Volume Ranking (2024)
  • 2.4 Global Inhaled Nitric Oxide Sales Volume by Company Players (2020-2025)
  • 2.5 Global Inhaled Nitric Oxide Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Inhaled Nitric Oxide Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Inhaled Nitric Oxide Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Inhaled Nitric Oxide
  • 2.9 Inhaled Nitric Oxide Market Competitive Analysis
    • 2.9.1 Inhaled Nitric Oxide Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Inhaled Nitric Oxide Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Nitric Oxide as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 High Purity iNO
    • 3.1.2 Standard Purity iNO
  • 3.2 Global Inhaled Nitric Oxide Sales Value by Type
    • 3.2.1 Global Inhaled Nitric Oxide Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Inhaled Nitric Oxide Sales Value, by Type (2020-2031)
    • 3.2.3 Global Inhaled Nitric Oxide Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Inhaled Nitric Oxide Sales Volume by Type
    • 3.3.1 Global Inhaled Nitric Oxide Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Inhaled Nitric Oxide Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Inhaled Nitric Oxide Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Inhaled Nitric Oxide Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Infants PPHN
    • 4.1.2 ARDS
    • 4.1.3 Other Diseases
  • 4.2 Global Inhaled Nitric Oxide Sales Value by Application
    • 4.2.1 Global Inhaled Nitric Oxide Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Inhaled Nitric Oxide Sales Value, by Application (2020-2031)
    • 4.2.3 Global Inhaled Nitric Oxide Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Inhaled Nitric Oxide Sales Volume by Application
    • 4.3.1 Global Inhaled Nitric Oxide Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Inhaled Nitric Oxide Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Inhaled Nitric Oxide Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Inhaled Nitric Oxide Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Inhaled Nitric Oxide Sales Value by Region
    • 5.1.1 Global Inhaled Nitric Oxide Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Inhaled Nitric Oxide Sales Value by Region (2020-2025)
    • 5.1.3 Global Inhaled Nitric Oxide Sales Value by Region (2026-2031)
    • 5.1.4 Global Inhaled Nitric Oxide Sales Value by Region (%), (2020-2031)
  • 5.2 Global Inhaled Nitric Oxide Sales Volume by Region
    • 5.2.1 Global Inhaled Nitric Oxide Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Inhaled Nitric Oxide Sales Volume by Region (2020-2025)
    • 5.2.3 Global Inhaled Nitric Oxide Sales Volume by Region (2026-2031)
    • 5.2.4 Global Inhaled Nitric Oxide Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Inhaled Nitric Oxide Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Inhaled Nitric Oxide Sales Value, 2020-2031
    • 5.4.2 North America Inhaled Nitric Oxide Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Inhaled Nitric Oxide Sales Value, 2020-2031
    • 5.5.2 Europe Inhaled Nitric Oxide Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Inhaled Nitric Oxide Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Inhaled Nitric Oxide Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Inhaled Nitric Oxide Sales Value, 2020-2031
    • 5.7.2 South America Inhaled Nitric Oxide Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Inhaled Nitric Oxide Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Inhaled Nitric Oxide Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Inhaled Nitric Oxide Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Inhaled Nitric Oxide Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Inhaled Nitric Oxide Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Inhaled Nitric Oxide Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Inhaled Nitric Oxide Sales Value, 2020-2031
    • 6.3.2 United States Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Inhaled Nitric Oxide Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Inhaled Nitric Oxide Sales Value, 2020-2031
    • 6.4.2 Europe Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Inhaled Nitric Oxide Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Inhaled Nitric Oxide Sales Value, 2020-2031
    • 6.5.2 China Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Inhaled Nitric Oxide Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Inhaled Nitric Oxide Sales Value, 2020-2031
    • 6.6.2 Japan Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Inhaled Nitric Oxide Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Inhaled Nitric Oxide Sales Value, 2020-2031
    • 6.7.2 South Korea Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Inhaled Nitric Oxide Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Inhaled Nitric Oxide Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Inhaled Nitric Oxide Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Inhaled Nitric Oxide Sales Value, 2020-2031
    • 6.9.2 India Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Inhaled Nitric Oxide Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Mallinckrodt (INOmax)
    • 7.1.1 Mallinckrodt (INOmax) Company Information
    • 7.1.2 Mallinckrodt (INOmax) Introduction and Business Overview
    • 7.1.3 Mallinckrodt (INOmax) Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Mallinckrodt (INOmax) Inhaled Nitric Oxide Product Offerings
    • 7.1.5 Mallinckrodt (INOmax) Recent Development
  • 7.2 Linde (Noxivent)
    • 7.2.1 Linde (Noxivent) Company Information
    • 7.2.2 Linde (Noxivent) Introduction and Business Overview
    • 7.2.3 Linde (Noxivent) Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Linde (Noxivent) Inhaled Nitric Oxide Product Offerings
    • 7.2.5 Linde (Noxivent) Recent Development
  • 7.3 Air Liquide (KINOX)
    • 7.3.1 Air Liquide (KINOX) Company Information
    • 7.3.2 Air Liquide (KINOX) Introduction and Business Overview
    • 7.3.3 Air Liquide (KINOX) Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Air Liquide (KINOX) Inhaled Nitric Oxide Product Offerings
    • 7.3.5 Air Liquide (KINOX) Recent Development

8 Industry Chain Analysis

  • 8.1 Inhaled Nitric Oxide Industrial Chain
  • 8.2 Inhaled Nitric Oxide Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Inhaled Nitric Oxide Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Inhaled Nitric Oxide Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Inhaled Nitric Oxide Market Trends
  • Table 2. Inhaled Nitric Oxide Market Drivers & Opportunity
  • Table 3. Inhaled Nitric Oxide Market Challenges
  • Table 4. Inhaled Nitric Oxide Market Restraints
  • Table 5. Global Inhaled Nitric Oxide Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Inhaled Nitric Oxide Revenue Market Share by Company (2020-2025)
  • Table 7. Global Inhaled Nitric Oxide Sales Volume by Company (2020-2025) & (M L)
  • Table 8. Global Inhaled Nitric Oxide Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Inhaled Nitric Oxide Price by Company (2020-2025) & (US$/L)
  • Table 10. Key Manufacturers Inhaled Nitric Oxide Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Inhaled Nitric Oxide Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Inhaled Nitric Oxide
  • Table 13. Global Inhaled Nitric Oxide Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Nitric Oxide as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Inhaled Nitric Oxide Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Inhaled Nitric Oxide Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Inhaled Nitric Oxide Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Inhaled Nitric Oxide Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Inhaled Nitric Oxide Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Inhaled Nitric Oxide Sales Volume by Type: 2020 VS 2024 VS 2031 (M L)
  • Table 22. Global Inhaled Nitric Oxide Sales Volume by Type (2020-2025) & (M L)
  • Table 23. Global Inhaled Nitric Oxide Sales Volume by Type (2026-2031) & (M L)
  • Table 24. Global Inhaled Nitric Oxide Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Inhaled Nitric Oxide Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Inhaled Nitric Oxide Price by Type (2020-2025) & (US$/L)
  • Table 27. Global Inhaled Nitric Oxide Price by Type (2026-2031) & (US$/L)
  • Table 28. Global Inhaled Nitric Oxide Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Inhaled Nitric Oxide Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Inhaled Nitric Oxide Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Inhaled Nitric Oxide Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Inhaled Nitric Oxide Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Inhaled Nitric Oxide Sales Volume by Application: 2020 VS 2024 VS 2031 (M L)
  • Table 34. Global Inhaled Nitric Oxide Sales Volume by Application (2020-2025) & (M L)
  • Table 35. Global Inhaled Nitric Oxide Sales Volume by Application (2026-2031) & (M L)
  • Table 36. Global Inhaled Nitric Oxide Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Inhaled Nitric Oxide Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Inhaled Nitric Oxide Price by Application (2020-2025) & (US$/L)
  • Table 39. Global Inhaled Nitric Oxide Price by Application (2026-2031) & (US$/L)
  • Table 40. Global Inhaled Nitric Oxide Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Inhaled Nitric Oxide Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Inhaled Nitric Oxide Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Inhaled Nitric Oxide Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Inhaled Nitric Oxide Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Inhaled Nitric Oxide Sales Volume by Region (M L): 2020 VS 2024 VS 2031
  • Table 46. Global Inhaled Nitric Oxide Sales Volume by Region (2020-2025) & (M L)
  • Table 47. Global Inhaled Nitric Oxide Sales Volume by Region (2026-2031) & (M L)
  • Table 48. Global Inhaled Nitric Oxide Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Inhaled Nitric Oxide Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Inhaled Nitric Oxide Average Price by Region (2020-2025) & (US$/L)
  • Table 51. Global Inhaled Nitric Oxide Average Price by Region (2026-2031) & (US$/L)
  • Table 52. Key Countries/Regions Inhaled Nitric Oxide Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Inhaled Nitric Oxide Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Inhaled Nitric Oxide Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Inhaled Nitric Oxide Sales Volume, (2020-2025) & (M L)
  • Table 56. Key Countries/Regions Inhaled Nitric Oxide Sales Volume, (2026-2031) & (M L)
  • Table 57. Mallinckrodt (INOmax) Company Information
  • Table 58. Mallinckrodt (INOmax) Introduction and Business Overview
  • Table 59. Mallinckrodt (INOmax) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 60. Mallinckrodt (INOmax) Inhaled Nitric Oxide Product Offerings
  • Table 61. Mallinckrodt (INOmax) Recent Development
  • Table 62. Linde (Noxivent) Company Information
  • Table 63. Linde (Noxivent) Introduction and Business Overview
  • Table 64. Linde (Noxivent) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 65. Linde (Noxivent) Inhaled Nitric Oxide Product Offerings
  • Table 66. Linde (Noxivent) Recent Development
  • Table 67. Air Liquide (KINOX) Company Information
  • Table 68. Air Liquide (KINOX) Introduction and Business Overview
  • Table 69. Air Liquide (KINOX) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
  • Table 70. Air Liquide (KINOX) Inhaled Nitric Oxide Product Offerings
  • Table 71. Air Liquide (KINOX) Recent Development
  • Table 72. Key Raw Materials Lists
  • Table 73. Raw Materials Key Suppliers Lists
  • Table 74. Inhaled Nitric Oxide Downstream Customers
  • Table 75. Inhaled Nitric Oxide Distributors List
  • Table 76. Research Programs/Design for This Report
  • Table 77. Key Data Information from Secondary Sources
  • Table 78. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Inhaled Nitric Oxide Product Picture
  • Figure 2. Global Inhaled Nitric Oxide Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Inhaled Nitric Oxide Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Inhaled Nitric Oxide Sales Volume (2020-2031) & (M L)
  • Figure 5. Global Inhaled Nitric Oxide Sales Price (2020-2031) & (US$/L)
  • Figure 6. Inhaled Nitric Oxide Report Years Considered
  • Figure 7. Global Inhaled Nitric Oxide Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Inhaled Nitric Oxide Players Sales Volume Ranking (2024) & (M L)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Inhaled Nitric Oxide Revenue in 2024
  • Figure 10. Inhaled Nitric Oxide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. High Purity iNO Picture
  • Figure 12. Standard Purity iNO Picture
  • Figure 13. Global Inhaled Nitric Oxide Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Inhaled Nitric Oxide Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Inhaled Nitric Oxide Sales Volume by Type (2020 VS 2024 VS 2031) & (M L)
  • Figure 16. Global Inhaled Nitric Oxide Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Inhaled Nitric Oxide Price by Type (2020-2031) & (US$/L)
  • Figure 18. Product Picture of Infants PPHN
  • Figure 19. Product Picture of ARDS
  • Figure 20. Product Picture of Other Diseases
  • Figure 21. Global Inhaled Nitric Oxide Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Inhaled Nitric Oxide Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Inhaled Nitric Oxide Sales Volume by Application (2020 VS 2024 VS 2031) & (M L)
  • Figure 24. Global Inhaled Nitric Oxide Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Inhaled Nitric Oxide Price by Application (2020-2031) & (US$/L)
  • Figure 26. North America Inhaled Nitric Oxide Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Inhaled Nitric Oxide Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Inhaled Nitric Oxide Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Inhaled Nitric Oxide Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Inhaled Nitric Oxide Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Inhaled Nitric Oxide Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Inhaled Nitric Oxide Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Inhaled Nitric Oxide Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Inhaled Nitric Oxide Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Inhaled Nitric Oxide Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Inhaled Nitric Oxide Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Inhaled Nitric Oxide Sales Volume (%), (2020-2031)
  • Figure 38. United States Inhaled Nitric Oxide Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Inhaled Nitric Oxide Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Inhaled Nitric Oxide Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Inhaled Nitric Oxide Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Inhaled Nitric Oxide Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Inhaled Nitric Oxide Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Inhaled Nitric Oxide Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Inhaled Nitric Oxide Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Inhaled Nitric Oxide Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Inhaled Nitric Oxide Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Inhaled Nitric Oxide Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Inhaled Nitric Oxide Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Inhaled Nitric Oxide Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Inhaled Nitric Oxide Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Inhaled Nitric Oxide Industrial Chain
  • Figure 60. Inhaled Nitric Oxide Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed